Codiak
Biosciences is a biotechnology company that develops exosome for therapeutics and cancer diagnoses... Read moreCodiak
Biosciences is a biotechnology company that develops exosome for therapeutics and cancer diagnoses... Read more
News
Mar 11, 2024
Pharamceutical Technology
Codiak: Codiak BioSciences files patent for extracellular vesicles for repolarizing macrophages in cancer treatment
Jun 20, 2023
GlobalNewswire
Press Release: Codiak : Evox Therapeutics Acquires Exosome AAV Technology and Intellectual Property
Mar 27, 2023
Benzinga
Codiak: Codiak BioSciences Files For Chapter 11 Bankruptcy
Mar 03, 2023
Nasdaq
Codiak: Laurion Capital Management Now Owns 9.60% of Codiak BioSciences (CDAK)
Jan 23, 2023
Acrofan
Codiak: ATUM Announces Leap-In Transposase Licensing Agreement with Codiak Biosciences to Support Manufacturing of Exosome-Based Therapeutics
Nov 28, 2022
Life Care News
Codiak: Codiak BioSciences to Participate 5th Annual Evercore ISI
Nov 04, 2022
Zacks
Codiak: Codiak BioSciences, Inc. (CDAK) Reports Q3 Loss, Lags Revenue Estimates
Nov 03, 2022
Owler
Codiak Biosciences, Inc.: Codiak's revenue changed from $34.70M in Jun 2022 to $34.07M in Sep 2022
Oct 12, 2022
Yahoo
Codiak: Codiak Presents Preclinical Data Demonstrating its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants of SARS-CoV-2 and Related Sarbecoviruses
Oct 05, 2022
centralcharts
Press Release: Codiak : Codiak to Present New Preclinical Data Demonstrating Potent Monotherapy Activity of Two Engineered Exosome Intravenous Candidates Targeting Macrophages
Codiak Competitors
1
2
3
4
5
6
7
8
9
10